Search research articles
Contact Us
Filters
Showing results (81-90 of 143) with videos related to
Page
of 15
Sort By:
Cancer Chemotherapy and Pharmacology
|
March 26, 2021
Oral recombinant methioninase combined with paclitaxel arrests recalcitrant ovarian clear cell carcinoma growth in a patient-derived orthotopic xenograft (PDOX) nude-mouse model
Norihiko Sugisawa, Takashi Higuchi, Qinghong Han, et al.
Biochemical and Biophysical Research Communications
|
October 6, 2020
Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells
Jun Yamamoto, Qinghong Han, Sachiko Inubushi, et al.
Tissue & Cell
|
June 15, 2023
Colon-cancer liver metastasis is effectively targeted by recombinant methioninase (rMETase) in an orthotopic mouse model
Kentaro Miyake, Qinghong Han, Takashi Murakami, et al.
Cancer Genomics & Proteomics
|
December 24, 2021
Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction
Jun Yamamoto, Yusuke Aoki, Sachiko Inubushi, et al.
Cancer Genomics & Proteomics
|
February 24, 2025
Engineered Methioninase-expressing Tumor-targeting <i>Salmonella typhimurium</i> A1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine
Yutaro Kubota, Ming Zhao, Qinghong Han, et al.
Anticancer Research
|
December 30, 2023
Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer
Motokazu Sato, Qinghong Han, Yutaro Kubota, et al.
Iscience
|
April 18, 2022
Linkage of methionine addiction, histone lysine hypermethylation, and malignancy
Jun Yamamoto, Sachiko Inubushi, Qinghong Han, et al.
Anticancer Research
|
January 31, 2021
Reversion from Methionine Addiction to Methionine Independence Results in Loss of Tumorigenic Potential of Highly-malignant Lung-cancer Cells
Jun Yamamoto, Yusuke Aoki, Qinghong Han, et al.
Cancer Diagnosis & Prognosis
|
January 6, 2025
Prostate Cancer Patient With Lymph-node Metastasis Treated Only With Methionine Restriction Has Stable Disease for Two Years Demonstrated With PET/CT and PSMA-PET Scanning and PSA Testing
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Cancer Diagnosis & Prognosis
|
January 6, 2025
Complete Response (CR) in a Previously-progressing Chronic Lymphocytic Leukemia (CLL) Patient Treated With Methionine Restriction in Combination With First-line Chemotherapy
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 143) with videos related to
Sort By:
Page
of 15
Cancer Chemotherapy and Pharmacology
|
March 26, 2021
Oral recombinant methioninase combined with paclitaxel arrests recalcitrant ovarian clear cell carcinoma growth in a patient-derived orthotopic xenograft (PDOX) nude-mouse model
Norihiko Sugisawa, Takashi Higuchi, Qinghong Han, et al.
Biochemical and Biophysical Research Communications
|
October 6, 2020
Histone methylation status of H3K4me3 and H3K9me3 under methionine restriction is unstable in methionine-addicted cancer cells, but stable in normal cells
Jun Yamamoto, Qinghong Han, Sachiko Inubushi, et al.
Tissue & Cell
|
June 15, 2023
Colon-cancer liver metastasis is effectively targeted by recombinant methioninase (rMETase) in an orthotopic mouse model
Kentaro Miyake, Qinghong Han, Takashi Murakami, et al.
Cancer Genomics & Proteomics
|
December 24, 2021
Extent and Instability of Trimethylation of Histone H3 Lysine Increases With Degree of Malignancy and Methionine Addiction
Jun Yamamoto, Yusuke Aoki, Sachiko Inubushi, et al.
Cancer Genomics & Proteomics
|
February 24, 2025
Engineered Methioninase-expressing Tumor-targeting <i>Salmonella typhimurium</i> A1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine
Yutaro Kubota, Ming Zhao, Qinghong Han, et al.
Anticancer Research
|
December 30, 2023
Recombinant Methioninase Decreased the Effective Dose of Irinotecan by 15-fold Against Colon Cancer Cells: A Strategy for Effective Low-toxicity Treatment of Colon Cancer
Motokazu Sato, Qinghong Han, Yutaro Kubota, et al.
Iscience
|
April 18, 2022
Linkage of methionine addiction, histone lysine hypermethylation, and malignancy
Jun Yamamoto, Sachiko Inubushi, Qinghong Han, et al.
Anticancer Research
|
January 31, 2021
Reversion from Methionine Addiction to Methionine Independence Results in Loss of Tumorigenic Potential of Highly-malignant Lung-cancer Cells
Jun Yamamoto, Yusuke Aoki, Qinghong Han, et al.
Cancer Diagnosis & Prognosis
|
January 6, 2025
Prostate Cancer Patient With Lymph-node Metastasis Treated Only With Methionine Restriction Has Stable Disease for Two Years Demonstrated With PET/CT and PSMA-PET Scanning and PSA Testing
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Cancer Diagnosis & Prognosis
|
January 6, 2025
Complete Response (CR) in a Previously-progressing Chronic Lymphocytic Leukemia (CLL) Patient Treated With Methionine Restriction in Combination With First-line Chemotherapy
Sei Morinaga, Qinghong Han, Kohei Mizuta, et al.
Page
of 15